Cargando…
Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898046/ https://www.ncbi.nlm.nih.gov/pubmed/36739972 http://dx.doi.org/10.1016/j.cmi.2023.01.024 |
| _version_ | 1784882372641030144 |
|---|---|
| author | Zeng, Guangting Liu, Jing Liu, Shulan |
| author_facet | Zeng, Guangting Liu, Jing Liu, Shulan |
| author_sort | Zeng, Guangting |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9898046 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98980462023-02-06 Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al. Zeng, Guangting Liu, Jing Liu, Shulan Clin Microbiol Infect Letter to the Editor European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-06 2023-02-04 /pmc/articles/PMC9898046/ /pubmed/36739972 http://dx.doi.org/10.1016/j.cmi.2023.01.024 Text en © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Zeng, Guangting Liu, Jing Liu, Shulan Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al. |
| title | Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al. |
| title_full | Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al. |
| title_fullStr | Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al. |
| title_full_unstemmed | Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al. |
| title_short | Re: ‘efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis’ by Deng et al. |
| title_sort | re: ‘efficacy and safety of selective serotonin reuptake inhibitors in covid-19 management: a systematic review and meta-analysis’ by deng et al. |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898046/ https://www.ncbi.nlm.nih.gov/pubmed/36739972 http://dx.doi.org/10.1016/j.cmi.2023.01.024 |
| work_keys_str_mv | AT zengguangting reefficacyandsafetyofselectiveserotoninreuptakeinhibitorsincovid19managementasystematicreviewandmetaanalysisbydengetal AT liujing reefficacyandsafetyofselectiveserotoninreuptakeinhibitorsincovid19managementasystematicreviewandmetaanalysisbydengetal AT liushulan reefficacyandsafetyofselectiveserotoninreuptakeinhibitorsincovid19managementasystematicreviewandmetaanalysisbydengetal |